Medpace Holdings, Inc. (MEDP) Average PB Ratio
The current pb ratio for Medpace Holdings, Inc. (MEDP) is 22.13 as of Wednesday, June 17, 2026, shown against its trailing averages.
Average PB Ratio Chart
MEDP PB Ratio Averages
PB RATIO CURRENT
22.13
PB RATIO TTM
50.19
PB RATIO 3Y
28.39
PB RATIO 5Y
22.04
PB RATIO 10Y
13.11
PB RATIO 15Y
13.11
PB RATIO 20Y
13.11
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle